...
首页> 外文期刊>American Journal of Cancer Research >Heparanase promotes radiation resistance of cervical cancer by upregulating hypoxia inducible factor 1
【24h】

Heparanase promotes radiation resistance of cervical cancer by upregulating hypoxia inducible factor 1

机译:乙酰肝素酶通过上调缺氧诱导因子1促进子宫颈癌的放射抵抗

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Heparanase (HPSE1) is elevated in various types of cancers including cervical cancer, and correlated with poor prognosis. Current study is to investigate the effects of HPSE1 on radiation response in cervical cancer. Colony formation assays after radiation were performed to compare the radiation response among control, HPSE1 knockdown and HPSE1 overexpression HeLa cells. The mRNA and protein levels of HIF1, bFGF and VEGF were measured as indicators for the activity of HIF1 pathway. Xenograft mouse model were used to study the HPSE1 radiation regulator effects in vivo. Microvessel densities (MVD) were measured in xenograft tumor samples. The survival fractions were significantly lower in HPSE1 knockdown cells and higher in HPSE1 overexpression cells compared with control cells. The mRNA and protein levels of HIF1, VEGF and bFGF are decreased in HPSE1 knockdown cells and increased in HPSE1 overexpression cells. HIF1 inhibition eliminated the radiation protection effects by HPSE1 overexpression. Our results demonstrate HPSE1 is an important regulator of radiation response both in vivo and in vitro. Further studies are warranted to determine the underlie mechanism of how HPSE1 regulate HIF1 activity and the clinical effects of HPSE1 inhibitors in cervical cancer.
机译:乙酰肝素酶(HPSE1)在各种类型的癌症(包括宫颈癌)中升高,并且与不良预后相关。当前的研究是调查HPSE1对子宫颈癌放射反应的影响。进行辐射后的集落形成分析,以比较对照,HPSE1敲低和HPSE1过表达HeLa细胞之间的辐射反应。测量HIF1,bFGF和VEGF的mRNA和蛋白水平作为HIF1途径活性的指标。使用异种移植小鼠模型来研究HPSE1辐射调节剂在体内的作用。在异种移植肿瘤样品中测量微血管密度(MVD)。与对照细胞相比,HPSE1敲低细胞中的存活分数明显较低,而HPSE1过表达细胞中的存活分数则较高。 HPSE1敲低细胞中HIF1,VEGF和bFGF的mRNA和蛋白水平降低,而HPSE1过表达细胞中HIF1,VEGF和bFGF的mRNA和蛋白水平降低。 HIF1抑制消除了HPSE1过表达的辐射防护作用。我们的结果表明,HPSE1是体内和体外辐射反应的重要调节剂。有必要进行进一步的研究以确定HPSE1如何调节HIF1活性的基本机制以及HPSE1抑制剂在宫颈癌中的临床作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号